SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹39 Cr | ₹69 Cr | ₹96 Cr | ₹141 Cr | ₹185 Cr |
What is the latest Total Debt ratio of SUVEN PHARMACEUTICALS ?
Year | Total Debt |
---|---|
Mar2024 | ₹39 Cr |
Mar2023 | ₹69 Cr |
Mar2022 | ₹96 Cr |
Mar2021 | ₹141 Cr |
Mar2020 | ₹185 Cr |
How is Total Debt of SUVEN PHARMACEUTICALS Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹39 Cr | -44.23 | |
Mar2023 | ₹69 Cr | -27.64 | |
Mar2022 | ₹96 Cr | -32.33 | |
Mar2021 | ₹141 Cr | -23.78 | |
Mar2020 | ₹185 Cr | - |
Compare Total Debt of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹29,733.5 Cr | 11.1% | 2% | 91.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 11.1% |
2% |
91.6% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses